Cargando…

Quantification of time delay between screening and subsequent initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)–producing Enterobacterales: A post hoc subgroup analysis of the R-GNOSIS WP5 Trial

OBJECTIVES: The aim of this study was to quantify the time delay between screening and initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)–producing Enterobacterales (ESBL-E). METHODS: This study was a secondary analysis of contact isolation periods in a cluster-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maechler, Friederike, Schwab, Frank, Hansen, Sonja, Behnke, Michael, Bonten, Marc J., Canton, Rafael, Diaz Agero, Cristina, Fankhauser, Carolina, Harbarth, Stephan, Huttner, Benedikt D., Kola, Axel, Gastmeier, Petra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507499/ https://www.ncbi.nlm.nih.gov/pubmed/36912321 http://dx.doi.org/10.1017/ice.2022.285

Ejemplares similares

Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital
por: Díaz-Agero Pérez, Cristina, et al.
Publicado: (2019)

Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype
por: Sakellariou, Christian, et al.
Publicado: (2016)

Increase of vancomycin-resistant Enterococcus faecium strain type ST117 CT71 at Charité - Universitätsmedizin Berlin, 2008 to 2018
por: Weber, Anna, et al.
Publicado: (2020)

More than half of ESBL-E are susceptible to fluoroquinolones: admission prevalence data from eight non-ICUs in a German university hospital
por: Maechler, F, et al.
Publicado: (2015)

Split k-mer analysis compared to cgMLST and SNP-based core genome analysis for detecting transmission of vancomycin-resistant enterococci: results from routine outbreak analyses across different hospitals and hospitals networks in Berlin, Germany
por: Maechler, Friederike, et al.
Publicado: (2023)

Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022)

Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Isolated from Flies in the Urban Center of Berlin, Germany
por: Wetzker, Wibke, et al.
Publicado: (2019)

Prevalence of extended-spectrum betalactamase producing–Enterobacteriaceae (ESBL-E) carriage on admission at Geneva University Hospitals (HUG)
por: Fankhauser, C, et al.
Publicado: (2015)

O045: Acquisition of extended-spectrum beta-lactamase (ESBL) positive E.coli in the community: the impact of cultural background and diet
por: Leistner, R, et al.
Publicado: (2013)

SAPS2, APACHE2, SOFA, and Core-10-TISS upon admission as risk indicators for ICU-acquired infections: a retrospective cohort study
por: Ginter, Katharina, et al.
Publicado: (2023)

Effect of Finger Gnosis on Young Chinese Children’s Addition Skills
por: Zhang, Li, et al.
Publicado: (2020)

Risk factors for predicting extended-spectrum β-lactamase-producing Enterobacterales (ESBLE) infections in non-urinary isolates
por: Burgoon, Rachel, et al.
Publicado: (2023)

Risk Factors Associated with the Community-Acquired Colonization of Extended-Spectrum Beta-Lactamase (ESBL) Positive Escherichia Coli. An Exploratory Case-Control Study
por: Leistner, Rasmus, et al.
Publicado: (2013)

Detection of Extended-Spectrum β-Lactamases (ESBLs) and AmpC in Class A and Class B Carbapenemase-Producing Enterobacterales
por: Imkamp, Frank, et al.
Publicado: (2022)

Detection of Multidrug-Resistant Enterobacterales—From ESBLs to Carbapenemases
por: Noster, Janina, et al.
Publicado: (2021)

An interventional quasi-experimental study to evaluate the impact of a rapid screening strategy in improving control of nosocomial extended-spectrum beta-lactamase-producing Enterobacterales and carbapenemase-producing organisms in critically ill patients
por: Martischang, Romain, et al.
Publicado: (2022)

CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales
por: Mathers, Amy J, et al.
Publicado: (2021)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

904 Multidrug-Resistant Gram-Negative Bacteria (MRGN) in Intensive Care Units - Results from the German National Surveillance System for Nosocomial Infections (KISS)
por: Behnke, Michael, et al.
Publicado: (2014)

Prohibit WP2 – systematic review of national guidelines in European countries
por: Martin, M, et al.
Publicado: (2011)

2826. Epidemiology of Extended Spectrum Beta-lactamase (ESBL)-producing Enterobacterales and Antimicrobial Resistance in Urinary Tract Infection (UTI) and Acute Pyelonephritis (AP)
por: Fernandez, Maria, et al.
Publicado: (2023)

1225. Optimization of Antimicrobial Therapy for Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Bloodstream Infections Through Laboratory-Based Interventions
por: Yazdi, Mona, et al.
Publicado: (2023)

Secular trends in ESBL, MRSA and VRE incidence in German intensive care units
por: Leistner, R, et al.
Publicado: (2011)

GNOSIS: an R Shiny app supporting cancer genomics survival analysis with cBioPortal
por: King, Lydia, et al.
Publicado: (2022)

Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing Enterobacterales Isolated from Carriage Samples among HIV Infected Women in Yaoundé, Cameroon
por: Zemtsa, Ravalona Jessica, et al.
Publicado: (2022)

Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
por: Villegas, Maria Virginia, et al.
Publicado: (2021)

ESBL Activity, MDR, and Carbapenem Resistance among Predominant Enterobacterales Isolated in 2019
por: Bandy, Altaf, et al.
Publicado: (2021)

Requirements and constraints of arc design options on WP3, WP4, WP5: Deliverable D2.3
por: Chance, Antoine
Publicado: (2017)

Requirements and constraints of EIR design option on WP2, WP4, WP5: Milestone M3.3
por: Seryi, Andrei
Publicado: (2017)

E. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality
por: Leistner, R., et al.
Publicado: (2016)

The relation between finger gnosis and mathematical ability: why redeployment of neural circuits best explains the finding
por: Penner-Wilger, Marcie, et al.
Publicado: (2013)

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales
por: Tan, Xing, et al.
Publicado: (2021)

P078: Epidemiology of extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBL-E) during an epidemic, with screening of patients and healthcare workers
por: Agostinho, A, et al.
Publicado: (2013)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection
por: Leistner, Rasmus, et al.
Publicado: (2014)

1053. The β-Lactamase Inhibitor QPX7728 Restores the Activity of β-Lactam Agents against Contemporary Extended-Spectrum β-lactamase (ESBL)-Producing and Carbapenem-Resistant Enterobacterales (CRE) Isolates, Including Isolates Producing Metallo-β-lactamases
por: Lindley, Jill, et al.
Publicado: (2021)

Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases in Enterobacterales: Development of a Screening Panel Using the MALDI-TOF MS-Based Direct-on-Target Microdroplet Growth Assay
por: Correa-Martínez, Carlos L., et al.
Publicado: (2019)

Prevalence and acquisition rate of extended spectrum beta lactamase producing gram-negative organisms (ESBL-GNO) in general medical patients in Switzerland
por: Pasricha, J, et al.
Publicado: (2011)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_de048jb9f0evn9sv7aj7ibdvtl